Back to top
more

NovoCure Limited (NVCR)

(Delayed Data from NSDQ)

$18.08 USD

18.08
1,272,314

+0.18 (1.01%)

Updated Aug 19, 2024 04:00 PM ET

After-Market: $18.10 +0.02 (0.11%) 5:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (70 out of 250)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

NovoCure (NVCR) Reports Q1 Loss, Misses Revenue Estimates

by Zacks Equity Research

NovoCure (NVCR) delivered earnings and revenue surprises of 0.00% and -0.44%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

NovoCure (NVCR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

NovoCure (NVCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Options Traders Expect Huge Moves in NovoCure (NVCR) Stock

by Zacks Equity Research

Investors need to pay close attention to NovoCure (NVCR) stock based on the movements in the options market lately.

NovoCure (NVCR) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

NovoCure (NVCR) delivered earnings and revenue surprises of 13.33% and -1.30%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

NovoCure (NVCR) Q3 Earnings Preview: What to Look Out For

by Zacks Equity Research

NovoCure (NVCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NovoCure (NVCR) Catches Eye: Stock Jumps 7.4%

by Zacks Equity Research

NovoCure (NVCR) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

    NovoCure (NVCR) Shares March Higher, Can It Continue

    by Zacks Equity Research

    As of late, it has definitely been a great time to be an investor in NovoCure Limited (NVCR).

      NovoCure Limited (NVCR) Looks Good: Stock Adds 7.9% in Session

      by Zacks Equity Research

      NovoCure (NVCR) was a big mover last session, as the company saw its shares rise more than 7% on the day amid huge volumes.

        NovoCure (NVCR) Looks Good: Stock Adds 8.3% in Session

        by Zacks Equity Research

        NovoCure (NVCR) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

          NovoCure (NVCR) Jumps: Stock Rises 10.5%

          by Zacks Equity Research

          NovoCure (NVCR) was a big mover last session, as the company saw its shares rise over 10% on the day.

            Is NovoCure (NVCR) a Great Growth Stock?

            by Zacks Equity Research

            NovoCure (NVCR) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.